Searchable abstracts of presentations at key conferences in endocrinology

ea0063oc5.4 | Adrenal 1 | ECE2019

The splicing factor NOVA1 is overexpressed in pancreatic neuroendocrine tumors and related to increased aggressiveness and malignancy

Pedraza-Arevalo Sergio , Alors-Perez Emilia , Herrera-Martinez Aura D. , Blazquez-Encinas Ricardo , Sanchez-Sanchez Rafael , Ortega-Salas Rosa , Serrano-Blanch Raquel , Gahete Manuel D. , Luque Raul M , Castano Justo P

There is increasing evidence that alterations in alternative splicing can be linked to key tumor features in cancer. Dysregulations in the splicing machinery constitute the underlying cause in many of these alterations and, consequently, splicing and its control are emerging as a novel and transversal cancer hallmark, due to its association with different dysfunctions of tumor cells. In line with this, we discovered the existence of aberrantly spliced variants of somatostatin ...

ea0063gp202 | Diabetes: Pharmacotherapy | ECE2019

The growth hormone effect blocked with pegvisomant did not alter the free fat acid plasma concentration in pre-diebetic or type 2 diabetic patients treated with empagliflozin

da Rocha Aline Franco , Junior Paulo Sergio Pereira , Calefi Gabriela Simonetti , Morimoto Helena Kaminami , Marquezine Guilherme Figueiredo , Mazzuco Tania Longo , de Faria Eliana Cotta , Urbano Mariana Ragassi , Carrilho Alexandre Jose Faria

Context: Sodium-glucose cotransporter 2 (SGLT2) inhibitors induce glycosuria and improve glycemic control, β cell function and insulin sensitivity in type 2 diabetes mellitus (DM2). On the other hand, these drugs predispose to diabetic ketoacidosis by increasing the tonus of glucagon. Glucagon acts on the liver and has no relevant effect on peripheral lipolysis and release of free fatty acids (FFA) as a substrate for ketogenesis, an action attributed to growth hormone (GH...

ea0063p746 | Thyroid 2 | ECE2019

External beam radiotherapy in differentiated thyroid cancer: clinical experience in a large spainish multicentre study

Romero-Lluch Ana , Anda Emma , Santamaria Javier , Diez Juan Jose , Donnay Sergio , Galofre Juan Carlos , Menendez Edelmiro , Perez Begona , Sastre Julia , Alcazar Victoria , Blanco Concepcion , Iglesias Pedro , Pamplona Ma Jose , Navarro Elena

The role of adjuvant external beam radiotherapy (EBRT) in differenciated thyroid cancer (DTC) is controversial. It remains unknown whether EBRT in the neck following conventional treatment might improve progression-free survival (PFS) and overall survival (OS).Objective: To assess EBRT outcomes in patients with locally advanced DTC in terms of local disease progression, PFS and OS.Material and Methods: A multicentric retrospective ...

ea0049ep178 | Endocrine tumours and neoplasia | ECE2017

Dysregulation of the components of the splicing machinery in neuroendocrine tumors and its association with malignancy and aggressiveness

Pedraza-Arevalo Sergio , Alors-Perez Emilia , Herrera-Martinez Aura D. , del Rio-Moreno Mercedes , Sanchez-Sanchez Rafael , Ortega-Salas Rosa , Serrano-Blanch Raquel , Galvez-Moreno Maria A. , Gahete Manuel D. , Luque Raul M. , Castano Justo P.

Dysregulation of the splicing machinery is emerging as a novel cancer hallmark due to its association with multiple dysfunctions in tumor cells. An inappropriate function of the components of this machinery (spliceosome) could be primarily linked with the generation of tumor-associated aberrant splicing variants. In line with this, we have previously reported that overexpression of aberrantly spliced variants of somatostatin receptor 5 (sst5TMD4) and ghrelin (In1-ghrelin) is d...

ea0049ep698 | Obesity | ECE2017

Associations between the dysregulation of splicing machinery components and the development of hepatic steatosis in obese women

del Rio-Moreno Mercedes , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M , Gahete Manuel D

: Hepatic steatosis is a common obesity-associated pathology characterized by the accumulation of fat within the liver, which can progress to liver fibrosis, cirrhosis and ultimately lead to hepatocellular carcinoma. Remarkably, obesity and cancer course with a profound dysregulation of the genetic expression patterns and, particularly, with the aberrant expression of splicing variants that could contribute to the aggressiveness and comorbidities of these pathologies. Since th...

ea0049ep719 | Obesity | ECE2017

Testosterone deficiency in obese males: is insulin resistance the one to blame?

Souteiro Pedro , Magalhaes Daniela , Pedro Jorge , Oliveira Sofia Castro , Neves Joao Sergio , Belo Sandra , Costa Maria Manuel , Bettencourt-Silva Rita , Varela Ana , Queiros Joana , Freitas Paula , Carvalho Davide , Group AMTCO

Introduction: Obesity is a growing worldwide public health issue and it is associated with multiple comorbidities, namely the so called Male Obesity-associated Secondary Hypogonadism (MOSH). However, the mechanisms that explain this association are not fully understood.Methods: Cross-sectional study of 163 obese men that were evaluated for several clinical and analytic parameters. Testosterone deficiency was defined as: total testosterone <2.8 ng/ml ...

ea0049ep790 | Endocrine tumours and neoplasia | ECE2017

Altered expression of the components of the splicing machinery is associated to increased malignancy and expression of aberrant splicing variants in prostate cancer

Jimenez-Vacas Juan M , Gahete Manuel D , Pedraza-Arevalo Sergio , del Rio-Moreno Mercedes , Hormaechea-Agulla Daniel , Gomez-Gomez Enrique , Carrasco-Valiente Julia , del Mar Moreno Maria , Jose Requena-Tapia Maria , Castano Justo P , Luque Raul M

: Prostate cancer (PCa) is the most common cancer among men in developed countries. Unfortunately, the heterogeneity of this malignancy hinders the finding of new biomarkers and therapeutic tools. A potential factor contributing to PCa is alternative splicing, which can generate the appearance of oncogenic variants involved in PCa aggressiveness. Thus, we hypothesized that the alteration of the splicing machinery (spliceosome components and splicing factors (SFs)) could be ass...

ea0041oc3.1 | Diabetes prediction &amp; complications | ECE2016

Identification of a spliceosome-associated fingerprint with potential to predict development of type 2 diabetes in high-risk patients

Luque Raul M. , Gahete Manuel D. , Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Camargo Antonio , Delgado-Lista Javier , Gracia-Navarro Francisco , Perez-Jimenez Francisco , Lopez-Miranda Jose , Castano Justo P.

Prevalence of metabolic syndrome (MetS) and type-2 Diabetes (T2D) is growing dramatically worldwide. Loss of phenotypic flexibility, i.e. the difficulty to cope with different stressors to maintain metabolic homeostasis, contributes critically to the development of MetS/T2DM. Thus, it is essential to identify the key modifiers of phenotypic plasticity that define an individual’s susceptibility to develop T2DM. In this scenario, emerging evidence indicates that, under adve...

ea0041gp131 | Obesity | ECE2016

The liver of obese patients with hepatic steatosis exhibits a severe dysregulation of key splicing machinery components as compared to obese patients without hepatic steatosis

Rio-Moreno Mercedes del , Pedraza-Arevalo Sergio , Gonzalez-Rubio Sandra , Ferrin Gustavo , Gahete Manuel D , Rodriguez-Peralvarez Manuel , Kineman Rhonda D , Ibanez-Costa Alejandro , de la Mata Manuel , Castano Justo P , Luque Raul M

Obesity, a disease that is growing at epidemic proportions worldwide, is caused by a combination of genetic and lifestyle factors. One of the most common pathologies associated with obesity is hepatic steatosis, an accumulation of fat within the liver that can progress to liver fibrosis, cirrhosis, and ultimately lead to hepatocellular carcinoma. There is emerging evidence that alternative mRNA splicing, the key mechanism providing transcript and protein diversity, is dysregul...

ea0041ep793 | Obesity | ECE2016

Obstructive sleep apnoea syndrome – longitudinal outcomes and improvement predictors after bariatric surgery

Bettencourt-Silva Rita , Magalhaes Daniela , Souteiro Pedro , Sergio Neves Joao , Castro Oliveira Sofia , Manuel Costa Maria , Saavedra Ana , Bettencourt-Silva Marilia , Almeida Leonor , Drummond Marta , Queiros Joana , Varela Ana , Freitas Paula , Correia Flora , Carvalho Davide , AMTCO group Davide

Background: Bariatric surgery has been associated with a decrease in multiple obesity-related comorbidities including obstructive sleep apnoea syndrome (OSA). This study aims to access the OSA evolution in obese patients who underwent bariatric surgery.Methods: Retrospective longitudinal study of a population of obese patients who underwent bariatric surgery between January/2010 and July/2014 in our centre. Only patients who have undergone polysomnograph...